89 related articles for article (PubMed ID: 1682045)
1. N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1.
Gattegno L; Sadeghi H; Saffar L; Bladier D; Clerget-Raslain B; Gluckman JC; Bahraoui E
Carbohydr Res; 1991 Jun; 213():79-93. PubMed ID: 1682045
[TBL] [Abstract][Full Text] [Related]
2. Mannosyl/N-acetyl-beta-D-glucosaminyl binding properties of the envelope glycoprotein of human immunodeficiency virus type 2.
Haïdar M; Gluckman JC; Gattegno L
Glycobiology; 1992 Oct; 2(5):429-35. PubMed ID: 1281021
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
Haidar M; Seddiki N; Gluckman JC; Gattegno L
Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
[TBL] [Abstract][Full Text] [Related]
4. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
[TBL] [Abstract][Full Text] [Related]
5. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
Rabehi L; Ferriere F; Saffar L; Gattegno L
Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus.
Seddiki N; Ramdani A; Saffar L; Portoukalian J; Gluckman JC; Gattegno L
Biochim Biophys Acta; 1994 Feb; 1225(3):289-96. PubMed ID: 8312376
[TBL] [Abstract][Full Text] [Related]
7. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
[TBL] [Abstract][Full Text] [Related]
8. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
Andersen O; Sørensen AM; Svehag SE; Fenouillet E
Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Fenouillet E; Miquelis R; Drillien R
Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
[TBL] [Abstract][Full Text] [Related]
10. Sugar-binding sites with specificity to N-acetyl-D-glucosaminides in middle ear mucosa of the guinea pig.
Tanimura F; Morioka H
Eur Arch Otorhinolaryngol; 1993; 250(6):337-41. PubMed ID: 7505088
[TBL] [Abstract][Full Text] [Related]
11. Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine.
Shilatifard A; Merkle RK; Helland DE; Welles JL; Haseltine WA; Cummings RD
J Virol; 1993 Feb; 67(2):943-52. PubMed ID: 8419650
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.
Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP
AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
Wells DE; Compans RW
Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.
Chirmule N; Goonewardena H; Pahwa S; Pasieka R; Kalyanaraman VS; Pahwa S
J Biol Chem; 1995 Aug; 270(33):19364-9. PubMed ID: 7642615
[TBL] [Abstract][Full Text] [Related]
16. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
[TBL] [Abstract][Full Text] [Related]
17. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
18. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
Rodriguez D; Rodriguez JR; Esteban M
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
[TBL] [Abstract][Full Text] [Related]
19. Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation.
Hemming A; Bolmstedt A; Flodby P; Lundberg L; Gidlund M; Wigzell H; Olofsson S
Arch Virol; 1989; 109(3-4):269-76. PubMed ID: 2558637
[TBL] [Abstract][Full Text] [Related]
20. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
